Items where Author is "Symonds, P"

COOK, K., XUE, W., SYMONDS, P., DANIELS, I., GIJON, M., BOOCOCK, D., COVENEY, C., MILES, A., SHAH, S., ATABANI, S., CHOUDHURY, R., VAGHELA, P., WESTON, D., METHERINGHAM, R., BRENTVILLE, V. and DURRANT, L., 2021. Homocitrullination of lysine residues mediated by myeloid derived suppressor cells in the tumour environment is a target for cancer immunotherapy. Journal for ImmunoTherapy of Cancer, 9 (7): e001910.

BRENTVILLE, V.A., VANKEMMELBEKE, M., METHINGHAM, R.L., SYMONDS, P., COOK, K.W., URBANOWICZ, R.A., TSOLERIDIS, T., COLEMAN, C.M., CHANG, K.-C., SKINNER, A., DUBININA, E., DANIELS, I., POCKLEY, A.G., SHAH, S., DIXON, J.E., ADAMS, S.E., PASTON, S.J., DALY, J.M., BALL, J.K. and DURRANT, L.G., 2021. A novel bivalent DNA vaccine encoding both spike protein receptor-binding domain and nucleocapsid protein of SARS-CoV-2 to elicit T cell and neutralising antibody responses that cross react with variants. Cold Spring Harbor Laboratory. (Submitted)